5 Health Care Stocks On The Rise

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 40 points (-0.3%) at 14,679 as of Wednesday, April 24, 2013, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,751 issues advancing vs. 1,159 declining with 143 unchanged.

The Health Care sector currently sits down 0.57 versus the S&P 500, which is unchanged. A company within the sector that increased today was Sanofi ( SNY), up 0.68. On the negative front, top decliners within the sector include Amgen ( AMGN), down 5.92, Vertex Pharmaceuticals ( VRTX), down 4.21, Celgene Corporation ( CELG), down 3.95, Gilead ( GILD), down 3.49 and Biogen Idec ( BIIB), down 1.90.

TheStreet Ratings group would like to highlight 5 stocks pushing the sector higher today:

5. Novo Nordisk A/S ( NVO) is one of the companies pushing the Health Care sector higher today. As of noon trading, Novo Nordisk A/S is up $3.90 (2.35) to $169.72 on heavy volume Thus far, 342,922 shares of Novo Nordisk A/S exchanged hands as compared to its average daily volume of 350,800 shares. The stock has ranged in price between $169.70-$171.89 after having opened the day at $171.18 as compared to the previous trading day's close of $165.82.

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. Novo Nordisk A/S has a market cap of $93.0 billion and is part of the drugs industry. The company has a P/E ratio of 4.0, below the S&P 500 P/E ratio of 17.7. Shares are up 1.6% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Novo Nordisk A/S as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Novo Nordisk A/S Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

4. As of noon trading, WellPoint ( WLP) is up $3.71 (5.35) to $73.04 on heavy volume Thus far, 2.6 million shares of WellPoint exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $71.39-$74.43 after having opened the day at $72.05 as compared to the previous trading day's close of $69.33.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $20.6 billion and is part of the health services industry. The company has a P/E ratio of 8.3, below the S&P 500 P/E ratio of 17.7. Shares are up 13.8% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full WellPoint Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

3. As of noon trading, Teva Pharmaceutical Industries ( TEVA) is up $0.86 (2.28) to $38.74 on average volume Thus far, 2.7 million shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $37.89-$38.82 after having opened the day at $37.89 as compared to the previous trading day's close of $37.87.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. Teva Pharmaceutical Industries has a market cap of $32.4 billion and is part of the drugs industry. The company has a P/E ratio of 16.8, below the S&P 500 P/E ratio of 17.7. Shares are up 1.4% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Teva Pharmaceutical Industries as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full Teva Pharmaceutical Industries Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

2. As of noon trading, Aetna ( AET) is up $1.10 (1.98) to $56.65 on average volume Thus far, 1.6 million shares of Aetna exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $56.40-$57.36 after having opened the day at $57.21 as compared to the previous trading day's close of $55.55.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $18.0 billion and is part of the health services industry. The company has a P/E ratio of 11.4, below the S&P 500 P/E ratio of 17.7. Shares are up 20.0% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Aetna Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

1. As of noon trading, UnitedHealth Group ( UNH) is up $0.50 (0.85) to $59.04 on average volume Thus far, 2.6 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 6.4 million shares. The stock has ranged in price between $58.85-$59.25 after having opened the day at $59.19 as compared to the previous trading day's close of $58.54.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $60.7 billion and is part of the health services industry. The company has a P/E ratio of 11.5, below the S&P 500 P/E ratio of 17.7. Shares are up 7.9% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full UnitedHealth Group Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home